Related Experiment Video
Updated: Aug 6, 2025
08:40
Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
59.1K
Pseudotyped Viruses for the Alphavirus Chikungunya Virus
Jiajing Wu1, Weijin Huang2, Youchun Wang3,4
1Beijing Yunling Biotechnology Co., Ltd, Beijing, China.
Advances in Experimental Medicine and Biology
|March 15, 2023
Summary
Chikungunya virus (CHIKV) research is limited by safety requirements. Pseudotyped CHIKV technology offers a safer method for developing treatments and vaccines against this debilitating mosquito-borne alphavirus.
Area of Science:
- Virology
- Infectious Diseases
- Public Health
Background:
- Alphavirus genus includes mosquito-borne pathogens like Chikungunya virus (CHIKV).
- CHIKV re-emerged in 2006, causing significant health problems due to persistent symptoms.
- Current research is hampered by the need for BSL-3 facilities for live CHIKV experiments.
Conclusions:
- Pseudotyped CHIKV is a valuable tool for advancing CHIKV research.
- Enables development of effective treatments and vaccines against CHIKV.
- Promotes exploration of therapeutic strategies for related alphaviruses.
